pubmed-article:21608528 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21608528 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:21608528 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:21608528 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
pubmed-article:21608528 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:21608528 | lifeskim:mentions | umls-concept:C1880355 | lld:lifeskim |
pubmed-article:21608528 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:21608528 | pubmed:dateCreated | 2011-6-16 | lld:pubmed |
pubmed-article:21608528 | pubmed:abstractText | c-Met is a transmembrane tyrosine kinase that mediates activation of several signaling pathways implicated in aggressive cancer phenotypes. In recent years, research into this area has highlighted c-Met as an attractive cancer drug target, triggering a number of approaches to disrupt aberrant c-Met signaling. Screening efforts identified a unique class of 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one kinase inhibitors, exemplified by 1. Subsequent SAR studies led to the development of 81 (MK-2461), a potent inhibitor of c-Met that was efficacious in preclinical animal models of tumor suppression. In addition, biochemical studies and X-ray analysis have revealed that this unique class of kinase inhibitors binds preferentially to the activated (phosphorylated) form of the kinase. This report details the development of 81 and provides a description of its unique biochemical properties. | lld:pubmed |
pubmed-article:21608528 | pubmed:language | eng | lld:pubmed |
pubmed-article:21608528 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21608528 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21608528 | pubmed:month | Jun | lld:pubmed |
pubmed-article:21608528 | pubmed:issn | 1520-4804 | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:YenPP | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:LumbKevin JKJ | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:MarshallC... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:KuniiKaikoK | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:SzewczakAlexa... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:QuXianluX | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:GuerinDavid... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:LimJongwonJ | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:DinsmoreChris... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:HatchHaroldH | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:KatzJason DJD | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:ReillyJohn... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:WangWenxianW | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:DahlbergWilli... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:LutterbachBar... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:PatelSangita... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:WalkerDeborah... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:JewellJames... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:GabardaAna... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:DeshmukhSujal... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:RickertKeith... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:SoissonStephe... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:DavisLenoraL | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:YoungJonathan... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:PanBo-ShengBS | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:NazefNaimN | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:MathvinkRober... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:HangGaozhenG | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:ZengQinwenQ | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:RosensteinCra... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:AltmanMichael... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:FalconeDaniel... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:HolmesRachael... | lld:pubmed |
pubmed-article:21608528 | pubmed:author | pubmed-author:SpencerKerrie... | lld:pubmed |
pubmed-article:21608528 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21608528 | pubmed:day | 23 | lld:pubmed |
pubmed-article:21608528 | pubmed:volume | 54 | lld:pubmed |
pubmed-article:21608528 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21608528 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21608528 | pubmed:pagination | 4092-108 | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:meshHeading | pubmed-meshheading:21608528... | lld:pubmed |
pubmed-article:21608528 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21608528 | pubmed:articleTitle | Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer. | lld:pubmed |
pubmed-article:21608528 | pubmed:affiliation | Department of Chemistry, Merck Research Laboratories, 33 Avenue Louis Pasteur, BMB-2-114, Boston, Massachusetts 02115, United States. jason_katz2@merck.com | lld:pubmed |
pubmed-article:21608528 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:21608528 | lld:chembl |